Chemed (CHE) Set to Announce Quarterly Earnings on Tuesday

Chemed (NYSE:CHE) will be releasing its earnings data after the market closes on Tuesday, October 29th. Analysts expect Chemed to post earnings of $5.31 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Chemed Trading Up 1.0 %

Shares of NYSE CHE opened at $602.98 on Monday. Chemed has a twelve month low of $516.03 and a twelve month high of $654.62. The firm has a 50-day moving average of $586.25 and a two-hundred day moving average of $569.41. The company has a market capitalization of $9.13 billion, a price-to-earnings ratio of 32.45, a PEG ratio of 2.44 and a beta of 0.44.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, August 12th. This is a positive change from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed’s dividend payout ratio is currently 10.76%.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the transaction, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Andrea R. Lindell sold 831 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total transaction of $474,924.81. Following the completion of the sale, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 9,144 shares of company stock worth $5,264,839. 3.32% of the stock is owned by insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.